Mitozolomide-induced sensitisation of mammalian cells in vitro to radiation.
作者信息
McKeage M J, Roberts P B
机构信息
Oncology Department, Wellington Hospital, New Zealand.
出版信息
Br J Cancer. 1989 Aug;60(2):182-4. doi: 10.1038/bjc.1989.247.
Abstract
摘要
相似文献
1
Mitozolomide-induced sensitisation of mammalian cells in vitro to radiation.米托唑胺体外诱导哺乳动物细胞对辐射的敏感性。
Br J Cancer. 1989 Aug;60(2):182-4. doi: 10.1038/bjc.1989.247.
2
Phase II evaluation of mitozolomide in ovarian cancer.卵巢癌中米托蒽醌的II期评估。 （注：原文中mitozolomide应为mitoxantrone，即米托蒽醌 ）
Br J Cancer. 1988 Jan;57(1):113-4. doi: 10.1038/bjc.1988.21.
3
Abbreviated phase I clinical trial of i.v. mitozolomide.静脉注射米托唑胺的简化I期临床试验。
Cancer Treat Rep. 1986 Jun;70(6):797-8.
4
Phase I clinical trial of mitozolomide.米托唑胺的I期临床试验。
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):801-5.
5
6
Isobologram analysis of the combined effects of anti-tumour platinum complexes and ionizing radiation on mammalian cells.抗肿瘤铂配合物与电离辐射对哺乳动物细胞联合作用的等效线图分析
Br J Cancer. 1980 Aug;42(2):292-6. doi: 10.1038/bjc.1980.229.
7
8
9
The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.关于米托唑胺的抗肿瘤活性和毒性，对潜在抗癌药物进行更广泛临床前评估的相关事宜。
Br J Cancer. 1988 Aug;58(2):139-43. doi: 10.1038/bjc.1988.180.
10
Hypoxic radiosensitization by FLAP.
Br J Radiol. 1987 Jun;60(714):601. doi: 10.1259/0007-1285-60-714-601-a.
本文引用的文献
1
Variations in several responses of HeLa cells to x-irradiation during the division cycle.在分裂周期中，海拉细胞对X射线照射的几种反应的变化。
Biophys J. 1963 Jan;3(1):11-33. doi: 10.1016/s0006-3495(63)86801-0.
2
The effects of X rays on BCNU-induced DNA crosslinking.X射线对卡氮芥诱导的DNA交联的影响。
Radiat Res. 1984 Jul;99(1):165-74.
3
4
5
Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent.抗肿瘤咪唑并四嗪类化合物。1. 新型广谱抗肿瘤药物8-氨基甲酰基-3-(2-氯乙基)咪唑并[5,1-d]-1,2,3,5-四嗪-4(3H)-酮的合成与化学性质
J Med Chem. 1984 Feb;27(2):196-201. doi: 10.1021/jm00368a016.
6
Antitumour imidazotetrazines--IV. An investigation into the mechanism of antitumour activity of a novel and potent antitumour agent, mitozolomide (CCRG 81010, M & B 39565; NSC 353451).抗肿瘤咪唑并四嗪类——IV。新型强效抗肿瘤药物米托唑胺（CCRG 81010，M&B 39565；NSC 353451）抗肿瘤活性机制的研究。
Biochem Pharmacol. 1984 Jul 15;33(14):2185-92. doi: 10.1016/0006-2952(84)90652-x.
7
X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells.培养的中国仓鼠细胞在细胞生成周期中的X射线敏感性。
Radiat Res. 1966 Nov;29(3):450-74.
8
Phase I clinical trial of mitozolomide.米托唑胺的I期临床试验。
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):801-5.
9
10
In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma.新型抗癌药米托唑胺（NSC 353451）对Lewis肺癌的体内研究。
Cancer Chemother Pharmacol. 1986;16(2):125-8. doi: 10.1007/BF00256161.
Zotero 插件